For a global biopharma company, Healthskouts conducted a research project on diagnostic radiology, with specific focus on the trial readiness of radiology innovations in the areas of artificial intelligence, portable radiology and teleradiology.
Healthskouts provided a comprehensive description and analysis of current innovations & innovators in diagnostic radiology, covering:
CT
Ultrasound
MRI/MRA
X-ray
PET
Fluoroscopy
with a specific focus on AI applications (image analytics, diagnostics and workflow), miniaturization for remote & mHealth applications, data brokering services, and relevant industry initiatives (e.g. for data sharing/management, setting standards, efficiencies and workflows, etc.). Our therapeutic focus was on oncology, immunology, dermatology and neuroscience.
In addition to profiling all relevant companies along a set of maturity critiria, especially with regard to certification and clinical trials, we analysed the bigger trends & challenges around personalisation of imaging services, decentralised & community trials, Covid-related trends, and geographic trends.
Methodologically, we relied on our proprietary databases of digital health innovations and conducted an additional systematic scan of the market. We also screened the scientific literature and clinical trials databases for relevant trials and evidence, and we reviewed all pertinant commentary and analysis by industry experts and industry bodies. Finally, we wrote up our key findings in a 160 slide deck and another 100+ slide Appendix of company and platform profiles.
The report and presentation was well-received by the client and is currently informing their radiology strategy in multiple therapeutic areas.
